Company Filing History:
3 out of 109 
2 out of 138 
2 out of 1,454 
Years Active: 2018-2024
Title: The Innovative Contributions of Sophie Jadot
Introduction
Sophie Jadot is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that modulate human TNFa activity. With a total of 5 patents to her name, her work has the potential to impact various medical conditions.
Latest Patents
Among her latest patents is a series of fused pentacyclic imidazole derivatives. These compounds are recognized as potent modulators of human TNFa activity, which can be beneficial in the treatment and prevention of a wide range of human ailments. These include autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. Specifically, her invention focuses on 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and their analogs.
Career Highlights
Sophie has worked with notable companies in the pharmaceutical industry, including UCB Biopharma Srl and UCB Biopharma Sprl. Her experience in these organizations has allowed her to collaborate on innovative projects that advance medical science.
Collaborations
Some of her coworkers include Jag Paul Heer and Michael Deligny. Their collaborative efforts have contributed to the success of her inventions and the advancement of their respective fields.
Conclusion
Sophie Jadot's innovative work in the pharmaceutical industry showcases her dedication to improving human health through her inventions. Her contributions are paving the way for new treatments and therapies that can address a variety of medical challenges.